Strata Research :: Patient research

It typically takes 10-12 years to bring a new medicine to market

The average cost for developing a new medicine is £550 million pounds

In real terms, medicine prices are around 24 per cent lower than 10 years ago

Medicines account for around only 10% of NHS costs

The Nobel Prize in Physiology or Medicine has been awarded 101 times

The NHS employs more than 1.7 million people

The youngest person to receive the Nobel Laureate in Medicine was Frederick G Banting in 1923 for the discover of insulin

The NHS budget is over £100 billion per annum

In 2009 886 million prescription items were dispensed in England

On average, only one or two of every 10,000 substances synthesised in laboratories, will successfully pass all the stages to become marketable medicines

The value of UK pharmaceutical exports in 2007 was £14.6 billion

In 2007, the pharmaceutical industry invested approximately €26,000 million in R&D in Europe

The United States is the leading inventor of new molecules in the world

The pharmaceutical and biotechnology sector spends more on R & D investments than any other industrial sector

North America (USA & Canada) represents the world’s largest market for pharmaceutical sales

In 2009 the average net ingredient cost per prescription item in England was £9.64

In 2001 the European Union adopted the EU Clinical Trials Directive as a framework for good management in trials of medicines for human use

Worldwide an average of 36% of the retail price of a medicine does not revert to the manufacturer but goes to distributors (pharmacists and wholesalers) and the State

In 2006 the average amount spent on healthcare (public and private) in European countries was 8.9% of GDP

26,145 unique investigators conducted FDA-regulated clinical trials world wide in 2007

The Medical Research Council spent £704.2 million on research in 2008/09

Patient research

Back to our work

About 50% of our work is patient research and growing. Our clients are thinking more and more about patient strategies and how they can leverage the patient experience into their marketing to HCPs and / or to healthcare authorities.

Patient projects are sometimes stand alone and sometimes conducted in tandem with HCP research.

Why strata?

We have a thoughtful and sensitive approach to ensure we get to the right patients and the right design to get to the right issues, and sensitive monitoring taking into account the patient's situation.

We have a deep understanding with years of experience of understanding patients. Through our work and local country experience we understand patients across Europe.

Projects conducted recently include:

Pan-European qualitative work with sufferers of chronic lymphocytic leukaemia
Pan-European work with sufferers of rheumatoid arthritis
Work in the UK with heroin substitution users
Work in the UK with sufferers of IBD

Back to our work

created: 2011-12-02

An evening with Daniel Kahneman

Daniel Kahneman, doyen of behavioural economics, recently gave a fascinating talk at the Royal Institution. And I do mean a ‘talk’. No props. No PowerPoint slides. Just Daniel Kahneman in an armchair, regaling the audience with accounts of his research with co-worker Amos Tversky, followed by plenty of time for questions and discussion. Because so many of his

created: 2011-10-05

Neuromarketing seminar

The Royal Institute – where ‘science meets the world’ - is just around the corner from our offices and a group of us popped round yesterday evening to hear three fascinating and passionate views of neuromarketing.

Dr Pradeen, brand management consultant, was an enthusiastic and articulate advocate, Graham Lawton, senior editor with New Scientist described the case stud

created: 2011-10-03

Embracing Innovation (and burgers)

Two weeks ago Strata attended the BHBIA Members' Exchange Forum event 'Embracing Innovation'.

It was a wonderful event that covered several different topics. The session kicked off with 'An update and discussion of the ethics, guidelines and practicalities of undertaking social media research', a very useful reminder of implications of market research and social media, a very topical di

created: 2011-09-29

A bit of community spirit

Every so often the crew here at Strata and Seven Stones take time out to do some fundraising for charity or voluntary work. A week ago, we shut up shop for a day to do just that.

The Trinity Centre is a key part of the South East London community, it is a Methodist Church and Youth and Community Centre. It is a safe haven

created: 2011-09-28

Strata are EphMRA Finalists for Neuroscientific Case Study

We are rather excited after EphMRA contacted us to inform us that we are finalists for the EphMRA Case Study Award!

This is for a case study we carried out last year using our in-house Neuroscientific techniques.

Wish us luck! We find out at the EphMRA Conference in Paris on 19-21 June 2012, we hope to see you there!

For more information regarding the EphMRA 2012 confere

created: 2011-09-27

Neuroscience finally becomes hot topic!

We've been researching, validating and using our Neuroscientific techniques over the past 3 years and finally Neuroscience has caught on in market research!

It certainly is an exciting time for new research methods to come into the spotlight. We've always adopted psychological approaches to qualitative interviewing, be they association techniques, completion tasks, anologies, metaphors

created: 2011-03-04

We've been nominated for an award!

Strata Research has been nominated for an industry award - a BHBIA BOBI award for 'Best Innovative Approach'.

It's exciting to be shortlisted as one of three finalists, the BOBI nomination was for the use of our Implicit Techniques, which was designed to understand a complex prescribing issue for a debilitating chronic condition.

The BHBIA Annual Conference and BOBI Award

created: 2010-06-04

Strata carries out study amongst Marketing Professionals

Strata Research recently conducted a study amongst senior healthcare marketing and branding professionals from several large biotechs and Top 10 Pharma companies about their changing roles in the industry.

More details to follow soon.